HIV-related stigma, disclosure and social support: experiences among young pregnant and postpartum women living with HIV in South Africa

AIDS Care. 2023 Mar;35(3):399-405. doi: 10.1080/09540121.2022.2121957. Epub 2022 Sep 14.

Abstract

ABSTRACTYoung pregnant and postpartum women living with HIV (WLHIV) are at high risk of poor antiretroviral therapy (ART) outcomes, which may be driven partly by HIV-related stigma. We conducted in-depth interviews with 20 pregnant and postpartum WLHIV aged 19-24 years to understand how different forms of HIV-related stigma manifest in their lives, as well as their experiences of HIV-status disclosure and social support. Participants described profound levels of perceived stigma in their community, including gossip from other young women and judgement from older adults. Consequently, participants disclosed to a limited number of people to avoid being stigmatised, and disclosure to peers was especially uncommon. However, disclosure in certain situations was described as leading to emotional support and support for ART adherence, and disclosure to older WLHIV resulted in participants having a role model. Finally, participants expressed varied ways in which they accept, speak about, and live with their HIV diagnosis. These data provide a rich understanding of the experiences of HIV-related stigma in this population and point to the need for psychosocial interventions focussed on acceptance and coping with an HIV-positive diagnosis despite profound levels of perceived stigma, as well as navigating decisions around the targets and timing of disclosure.Trial registration: ClinicalTrials.gov identifier: NCT04036851.

Keywords: HIV-related stigma; South Africa; disclosure; pregnancy; social support; young women.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Anti-Retroviral Agents / therapeutic use
  • Disclosure*
  • Female
  • HIV Infections* / psychology
  • Humans
  • Postpartum Period
  • Pregnancy
  • Social Stigma
  • Social Support
  • South Africa / epidemiology

Substances

  • Anti-Retroviral Agents

Associated data

  • ClinicalTrials.gov/NCT04036851